Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ACACB | O00763 | 1/20 | 0.36 |
| ▸ | ACACA | Q13085 | 1/20 | 0.36 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19342748 | 0.80 | KDM4E (0.44) | KMT2AKDM4EACACBACACAPRKCZ | |
| SCHEMBL27809455 | 0.79 | KMT2A (0.36) | KMT2AKDM4EACACBACACAPRKCZ | |
| SCHEMBL28080901 | 0.79 | ACACB (0.36) | KMT2AKDM4EACACBACACAPRKCZ | |
| SCHEMBL1918148 | 0.77 | EGLN1 (0.40) | KMT2AKDM4EACACBACACAPRKCZ | |
| SCHEMBL3712699 | 0.77 | KMT2A (0.38) | KMT2AKDM4EPOLBMAPK1MAPT | |
| SCHEMBL158112 | 0.75 | ACACB (0.45) | KMT2AKDM4EACACBACACAPRKCZ | |
| SCHEMBL3640946 | 0.75 | ACACB (0.36) | KMT2AKDM4EACACBACACAPRKCZ | |
| SCHEMBL28048356 | 0.74 | ACACB (0.44) | KMT2AKDM4EACACBACACAPRKCZ | |
| SCHEMBL8848140 | 0.74 | ACACB (0.44) | KMT2AKDM4EACACBACACAPRKCZ | |
| SCHEMBL9754820 | 0.73 | KMT2A (0.37) | KMT2AKDM4EACACBACACAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113045501-B | Preparation method of telmisartan intermediate | 石家庄学院 | 2022-09-30 | — | — | CN | claimed |
| CN-113045501-A | Preparation method of telmisartan intermediate | 石家庄学院 | 2021-06-29 | — | — | CN | claimed |
| CN-113045501-B | Preparation method of telmisartan intermediate | 石家庄学院 | 2022-09-30 | — | — | CN | disclosed |
| CN-113045501-B | Preparation method of telmisartan intermediate | 石家庄学院 | 2022-09-30 | — | — | CN | disclosed |
| CN-113045501-A | Preparation method of telmisartan intermediate | 石家庄学院 | 2021-06-29 | — | — | CN | disclosed |
| CN-113045501-A | Preparation method of telmisartan intermediate | 石家庄学院 | 2021-06-29 | — | — | CN | disclosed |
| WO-2010081670-A2 | PROCESS FOR THE PREPARATION OF BENZIMIDAZOLES | LONZA LTD (CH) | 2010-07-22 | — | — | WO | disclosed |
| WO-2009123483-A1 | PROCESS FOR PREPARATION OF TELMISARTAN | ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) | 2009-10-08 | — | — | WO | disclosed |
| WO-2009123483-A1 | PROCESS FOR PREPARATION OF TELMISARTAN | ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) | 2009-10-08 | — | — | WO | disclosed |